Uro-vaxomⓇ의 도뇨관 관련 요로감염에서의 항균 효과
Antimicrobial Effect of Uro-vaxomⓇ in Catheter-Related Urinary Tract Infection
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Urinary tract infection (UTI) is a relatively common disease, and clinically it appears diversely like urethritis, cystitis, prostatitis, and acute pyelonephritis. E. coli which is the major causative microorganism of UTI, and accounts for 50% of hospital pathogens cultured in 40% of catheter-related UTI. We evaluated the preventive effect on UTI and inhibitory effect on complications of Uro-vaxomⓇ,and investigate the effect of Uro-vaxomⓇ in catheter induced UTI. Materials and Methods: A comprehensive electronic search was conducted using the Medline database to identify all publications relating to Uro-vaxomⓇ and catheter and UTI by using keywords Uro-vaxomⓇ,catheter, catheterization, urinary tract infection, cystitis, bacteriuria, antimicrobial agents, intensive care unit. Results: 227 literatures which were consistent with our purposes were searched; we intensively analyzed 26 literatures which were appropriate for our literature. All literature reported antimicrobial effects of Uro-vaxomⓇ. Conclusions: We identified that Uro-vaxomⓇ had a preventive effect on UTI associated with E. coli to patients who had catheterization.
Abstract
Purpose: Urinary tract infection (UTI) is a relatively common disease, and clinically it appears diversely like urethritis, cystitis, prostatitis, and acute pyelonephritis. E. coli which is the major causative microorganism of UTI, and accounts for 50% of hospital pathogens cultured in 40% of catheter-related UTI. We evaluated the preventive effect on UTI and inhibitory effect on complications of Uro-vaxomⓇ,and investigate the effect of Uro-vaxomⓇ in catheter induced UTI. Materials and Methods: A comprehensive electronic search was conducted using the Medline database to identify all publications relating to Uro-vaxomⓇ and catheter and UTI by using keywords Uro-vaxomⓇ,catheter, catheterization, urinary tract infection, cystitis, bacteriuria, antimicrobial agents, intensive care unit. Results: 227 literatures which were consistent with our purposes were searched; we intensively analyzed 26 literatures which were appropriate for our literature. All literature reported antimicrobial effects of Uro-vaxomⓇ. Conclusions: We identified that Uro-vaxomⓇ had a preventive effect on UTI associated with E. coli to patients who had catheterization.
참고문헌 (22)
- Stamm WE, "Catheter-associated urinary tract infections: epidemiology, pathogenesis, and prevention", Am J Med, 91(3B), pp.65S~71S (1991)
- Saint S, "Clinical and economic consequences of nosocomial catheter related bacteriuria", Am J Infect Control, 28(1), pp.68~75 (2000)
- Milan PB, "Catheter-associated and nosocomialurinary tract infections: antibiotic resistance and influence on commonly used antimicrobial therapy", Int Urol Nephrol, 41(3), pp.461~464 (2009)
- Crouzet J, "Control of the duration of urinary catheterization: impact on catheter-associated urinary tract infection", J Hosp Infect, 67(3), pp.253~257 (2007)
- Tammen H, "Immunobiotherapy with Uro-Vaxom in recurrent urinary tract infection. the german urinary tract infection study group", Br J Urol, 65(1), pp.6~9 (1990)
- Magasi P, "Uro- Vaxom and the management of recurrent urinary tract infection in adults: a randomized multicenter double-blind trial", Eur Urol, 26(2), pp.137~140 (1994)
- Schulman CC, "Oral Immunotherpay recurrent urinary tract infections: a double-blind, placebo-controlled multicenter study", J Urol, 150(3), pp.917~921 (1993)
- Goszczyk A, "Clinical assessment of Uro-Vaxom in the treatment and prophylaxis of recurrent urinary tract infection in children: preliminary results", Pol Merkur Lekarski, 8(46), pp.242~243 (2000)
- Hachen HJ, "Oral immunotherapy in paraplegic patients with chronic urinary tract infections: a double- blind, placebo-controlled trial", J Urol, 143(4), pp.759~762 (1990)
- 김건석, "A Prospective Multi-center Trial of Escherichia coli Extract for the Prophylactic Treatment of Patients with Chronically Recurrent Cystitis", Journal of Korean Medical Science, 25(3), pp.435~439 (2010), 대한의학회
- 이승주, "재발성 단순방광염 환자에서 유로박솜의 치료 효과 및 안전성: 다기관 공개 임상연구", Korean Journal of Urology, 48(4), pp.428~432 (2007), 대한비뇨기과학회
- Yoo JY, "Preliminary study on protective effect of Uro vaxomⓇ in the longterm urinary catheterized patients", Korean J UTII, 3(1), pp.95~98 (2008)
- EARSS annual report2008, "European antimicrobial resistance surveillance system(EARSS) management team", National Instituteof Public Health and the Environment, ~ (2009)
- 유광호, "최근 요로감염증의 주요 원인균과 항생제 감수성에 관한 고찰", Korean Journal of Urology, 48(6), pp.638~645 (2007), 대한비뇨기과학회
- Jacoby GA, "New mechanisms of bacterial resistance to antimicrobial agents", N Engl J Med, 324(9), pp.601~612 (1991)
- Nicolle LE, "Resistant pathogens in urinary tract infections", J Am Geriatr Soc, 50(Suppl 7), pp.S230~S235 (2002)
- Clec'h C, "Does catheter- associated urinary tract infection increase mortality in critically ill patients?", Infect Control Hosp Epidemiol, 28(12), pp.1367~1373 (2007)
- Cravens DD, "Urinary catheter management", Am Fam Phys, 61(2), pp.369~376 (2000)
- Verwaest C, "Randomized, controlled trial of selective digestive decontamination in 600 mechanically ventilated patients in a multidisciplinary intensive care unit", Crit Care Med, 25(1), pp.63~71 (1997)
- Olson NC, "Mediators and vascular effects in response to endotoxin", Br Vet J, 151(5), pp.489~522 (1995)
- Hockertz S, "Immunomodulating effect of lysed immunoactive fractions of selected Escherichia coli strains on the macrophage system. an in vitro study", Arzneimittelforschung, 40(9), pp.1068~1072 (1990)
- Lee SJ, "Anti-inflammatory effect of an Escherichia coli extract in a mouse model of lipopolysaccharide-induced cystitis", World J Urol, 24(1), pp.33~38 (2006)